|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 403/12 | |
| C07D 401/14 | |||
| C07D 405/14 | |||
| C07D 409/14 | |||
| C07D 417/14 | |||
| A61K 31/4025 | |||
| A61P 3/00 | |||
| A61P 35/00 | |||
| A61P 39/00 |
| (11) | Number of the document | 3063141 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14802535.6 |
| Date of filing the European patent application | 2014-10-28 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/062516 |
| Date | 2014-10-28 |
| (87) | Number | WO 2015/065937 |
| Date | 2015-05-07 |
| (30) | Number | Date | Country code |
| 201361897110 P | 2013-10-29 | US |
| (72) |
WANG, Bing, US
|
| (73) |
BioMarin Pharmaceutical Inc.,
105 Digital Drive, Novato, CA 94949,
US
|
| (54) | N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS |
| N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS |